Morcos Atef Awad

Dr. Morcos Atef Awad

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2016 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MAMorcos Atef Awad
Morcos Atef Awad
LCLawrence S. C. Czer
Lawrence S. C. Czer
MHMargaret Hou
Margaret Hou
SGSarah S. Golshani
Sarah S. Golshani
MGMichael Goltche
Michael Goltche
JKJon A. Kobashigawa
Jon A. Kobashigawa
Heart transplantation (HTx) surgically interrupts the parasympathetic vagal neurons and the intrinsic postganglionic sympathetic nerve fibers traveling from the stellate ganglia to the myocardium, causing axonal Wallerian degeneration and thus extrinsic cardiac denervation.[1][1], [2][2], [3][3], [4

1 July 2013 in Transplantation Proceedings
Verified
Journal Article
Closed access
DPD. Perkel
D. Perkel
LCL.S.C. Czer
L.S.C. Czer
RMR.P. Morrissey
R.P. Morrissey
ARA. Ruzza
A. Ruzza
MRM. Rafiei
M. Rafiei
JKJ.A. Kobashigawa
J.A. Kobashigawa

1 January 2014 in Transplantation Proceedings
Verified
Journal Article
Closed access
PKP. Kansara
P. Kansara
LCL. Czer
L. Czer
MAMorcos Atef Awad
Morcos Atef Awad
FAF. Arabia
F. Arabia
JMJ. Mirocha
J. Mirocha
JKJ. Kobashigawa
J. Kobashigawa

19 February 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MAMorcos Atef Awad
Morcos Atef Awad
LCLawrence S. C. Czer
Lawrence S. C. Czer
DEDominic Emerson
Dominic Emerson
SJStanley Jordan
Stanley Jordan
MRMichele A. De Robertis
Michele A. De Robertis
JKJon A. Kobashigawa
Jon A. Kobashigawa
Background: Combined heart and kidney transplantation ( HKT x) is performed in patients with severe heart failure and advanced renal insufficiency. We analyzed the long‐term survival after HKT x, the influence of age and dialysis status, the rates of cardiac rejection, and the influence of sensitization. Methods and Results: From June 1992 to December 2016, we performed 100 HKT x procedures. We compared older (≥60 years, n=53) with younger (<60 years, n=47) recipients, and recipients on preoperative dialysis (n=49) and not on dialysis (n=51). We analyzed actuarial freedom from any cardiac rejection, acute cellular rejection, and antibody‐mediated rejection, and survival rates by sensitized status with panel‐reactive antibody levels 50%, and compared these survival rates with those from the United Network for Organ Sharing database. There was no difference in 15‐year survival between the 2 age groups (35±12.4% and 49±17.3%, ≥60 versus <60 years; P =0.45). There was no difference in 15‐year survival between the dialysis and nondialysis groups (44±13.4% and 37±15.2%, P =0.95). Actuarial freedom from any cardiac rejection ( acute cellular rejection >0 or antibody‐mediated rejection >0) was 92±2.8% and 84±3.8%, acute cellular rejection (≥2R/3A) 98±1.5% and 94±2.5%, and antibody‐mediated rejection (≥1) 96±2.1% and 93±2.6% at 30 days and 1 year after HKT x. There was no difference in the 5‐year survival among recipients by sensitization status with panel‐reactive antibody levels 50% (82±5.9%, 83±10.8%, and 92±8.0%; P =0.55). There was no difference in 15‐year survival after HKT x between the United Network for Organ Sharing database and our center (38±3.2% and 40±10.1%, respectively; P =0.45). Conclusions: HKT x is safe to perform in patients 60 years and older or younger than 60 years and with or without dialysis dependence, with excellent outcomes. The degree of panel‐reactive antibody sensitization did not appear to affect survival after HKT x.

1 November 2015 in Transplantation Proceedings
Verified
Journal Article
Closed access
HRH.J. Reich
H.J. Reich
MAMorcos Atef Awad
Morcos Atef Awad
ARA. Ruzza
A. Ruzza
MRM.A. De Robertis
M.A. De Robertis
DRD. Ramzy
D. Ramzy
LCL.S. Czer
L.S. Czer

11 December 2014 in CardioVascular Journal of Africa
Verified
Journal Article
Open access
MAMorcos Atef Awad
Morcos Atef Awad
ARAndrea Ruzza
Andrea Ruzza
JMJames Mirocha
James Mirocha
SSSaman Setareh-Shenas
Saman Setareh-Shenas
JPJ. Robert Pixton
J. Robert Pixton
LCLawrence S.C. Czer
Lawrence S.C. Czer
Hypertension (HTN) is one of the causes of cardiovascular disease (CVD) in Africa, and may be associated with lower socio-economic status (SES). The prevalence of HTN is not well established in the Gambia or in Sierra Leone. A cross-sectional, population-based study of adults was conducted in the Gambia in 2000 and in Sierra Leone from 2001 to 2003 and in 2009. The study was conducted as part of the annual visit to countries in western Africa sponsored by a medical delegation from California. People from the Gambia and Sierra Leone were examined by the medical delegation and blood pressures were measured. A total of 2 615 adults were examined: 1 400 females and 1 215 males. The mean systolic blood pressure (SBP) of the females was 134.3 ± 29.7 mmHg, mean diastolic blood pressure (DBP) was 84.5 ± 17.5 mmHg, and 46.2% were hypertensive. The mean SBP of the males was 132.8 ± 28.5 mmHg, mean DBP was 82.8 ± 16.2 mmHg, and 43.2% were hypertensive. Overall prevalence of HTN in the subjects was 44.8%. Mean SBP, mean DBP and HTN prevalence increased with age decade, both in males and females. In addition, after age adjustment (known age), females had higher mean SBP (p = 0.042), mean DBP (p = 0.001) and rate of occurrence of HTN (p = 0.016) when compared with males. Prevalence rates of HTN in the Gambia and Sierra Leone were higher than 40% in males and females, and may be a major contributor to CVD in both countries. Due to the association of HTN with low SES, improvements in educational, public health, economic, non-governmental and governmental efforts in the Gambia and Sierra Leone may lead to a lower prevalence of HTN. The cause of the higher prevalence in women may be due to post-menopausal hormonal changes.